To address rising cost and risk pressures, improve innovation, and focus on core competencies, many science-based organizations across diverse industries including biopharmaceuticals are looking for ways to improve operational agility, lower costs, and collaborate more effectively with industry partners. Over time, these externalized collaboration networks increase in size and complexity. Many combine numerous partners with…